Matrix metalloproteinase production by COOH-terminal heparin-binding fibronectin fragment in rheumatoid synovial cells

Lab Invest. 2003 Feb;83(2):153-62. doi: 10.1097/01.lab.0000056999.08437.b2.

Abstract

Fibronectin with IIICS region is present in rheumatoid synovium, and fibronectin fragments are increased in rheumatoid joints. We investigated the ability of COOH-terminal heparin-binding fibronectin fragment (COOH-HBFN-f) containing IIICS to induce matrix metalloproteinase (MMP) production and the role of mitogen-activated protein kinase (MAPK) pathway and CS-1 sequence that can bind alpha4beta1 integrin in MMP induction by COOH-HBFN-f in rheumatoid synovial fibroblasts (RSF). When RSF in monolayer culture were incubated with COOH-HBFN-f, COOH-HBFN-f stimulated the production of MMP-1, MMP-3, and MMP-13 by RSF in association with activation of extracellular signal-regulated kinase, p38 MAPK, and c-Jun NH(2)-terminal kinase. Immunoprecipitation of cell lysates demonstrated the presence of alpha4 integrin in cultured RSF. Similar to COOH-HBFN-f, treatment with CS-1 synthetic peptide derived from IIICS resulted in increased MMP production and activation of the kinases, although the MMP levels were low. Preincubation of RSF with anti-alpha4 integrin antibody resulted in partial suppression of the COOH-HBFN-f-stimulated MMP production. Inhibition studies using protein kinase inhibitors (PD98059 and SB203580) showed that those MAPK pathways contributed to MMP up-regulation by COOH-HBFN-f and CS-1. Thus, the present results have clearly shown that COOH-HBFN-f and CS-1 stimulate MMP production in association with activation of MAPK pathways in RSF. Integrin alpha4beta1 may be partially involved in the MMP induction by COOH-HBFN-f.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Arthritis, Rheumatoid / enzymology*
  • Carrier Proteins / pharmacology
  • Cells, Cultured
  • Enzyme Induction
  • Enzyme Inhibitors / pharmacology
  • Fibronectins / pharmacology*
  • Flavonoids / pharmacology
  • Humans
  • Imidazoles / pharmacology
  • Integrin alpha4 / biosynthesis
  • JNK Mitogen-Activated Protein Kinases
  • Matrix Metalloproteinases / biosynthesis*
  • Mitogen-Activated Protein Kinases / antagonists & inhibitors
  • Mitogen-Activated Protein Kinases / biosynthesis
  • Oligopeptides / pharmacology
  • Peptide Fragments / pharmacology
  • Pyridines / pharmacology
  • Synovial Membrane / drug effects
  • Synovial Membrane / enzymology*
  • Synovial Membrane / pathology
  • p38 Mitogen-Activated Protein Kinases

Substances

  • Carrier Proteins
  • Enzyme Inhibitors
  • Fibronectins
  • Flavonoids
  • Imidazoles
  • Oligopeptides
  • Peptide Fragments
  • Pyridines
  • glutamyl-isoleucyl-leucyl-aspartyl-valine
  • Integrin alpha4
  • JNK Mitogen-Activated Protein Kinases
  • Mitogen-Activated Protein Kinases
  • p38 Mitogen-Activated Protein Kinases
  • Matrix Metalloproteinases
  • SB 203580
  • 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one